Compatibility and Stability of Palonosetron Hydrochloride with Gentamicin, Metronidazole, or Vancomycin During Simulated Y-Site Administration

Kupiec, Thomas C; Ben, Michel; Trusley, Craig; Trissel, Lawrence A

A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of all issues and individual articles published by the Journal since 1997.

LEARN MORE

Compatibility and Stability of Palonosetron Hydrochloride with Gentamicin, Metronidazole, or Vancomycin During Simulated Y-Site Administration

Author(s): Kupiec Thomas C, Ben Michel, Trusley Craig, Trissel Lawrence A

Issue: Mar/Apr 2008 - Compounding Around the World
View All Articles in Issue

Page(s): 170-173

Compatibility and Stability of Palonosetron Hydrochloride with Gentamicin, Metronidazole, or Vancomycin During Simulated Y-Site Administration Page 1

Download in electronic PDF format for $75

Abstract: Palonosetron hydrochloride is a relatively long-acting selective 5-HT3 receptor antagonist that has been approved for the prevention of chemotherapy-induced nausea and vomiting and is being evaluated for the prevention of postoperative nausea and vomiting. The objective of this study was to evaluate the physical and chemical stability of palonosetron hydrochloride 50 mcg/mL when mixed with gentamicin sulfate 5 mg/mL, metronidazole 5 mg/mL, or vancomycin hydrochloride 5 mg/mL during simulated Y-site administration. Duplicate samples of palonosetron hydrochloride with each of the anti-infectives were tested. Samples were stored and evaluated for up to 4 hours at room temperature. Physical stability was assessed by turbidimetric and particulate measurements and visual inspection. Chemical stability was assessed by high-performance liquid chromatography. All of the admixtures were clear and colorless when viewed in normal fluorescent room light and when viewed with a Tyndall beam. Measured turbidity and particula

Related Keywords: palonosetron hydrochloride, selective 5-HT3 receptor antagonist, 5-HT3 blocker, nausea, vomiting, chemotherapy, Y-site administration, drug admixtures, infusion, antibiotics, antimicrobial agents, gentamicin sulfate, metronidazole, vancomycin hydrochloride, compatibility, stability

Related Categories: GASTROENTEROLOGY, INFUSION, PEER-REVIEWED, STABILITIES, COMPATIBILITIES, INFECTIOUS DISEASE

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Compatibility and Stability of Palonosetron Hydrochloride with Gentamicin, Metronidazole, or Vancomycin During Simulated Y-Site Administration Kupiec Thomas C, Ben Michel, Trusley Craig, Trissel Lawrence A	Mar/Apr 2008 Pg. 170-173
Compatibility and Stability of Palonosetron Hydrochloride with Four Neuromuscular Blocking Agents During Simulated Y-Site Administration Trusley Craig, Ben Michel, Kupiec Thomas C, Trissel Lawrence A	Mar/Apr 2008 Pg. 156-160
Compatibility and Stability of Palonosetron Hydrochloride and Propofol During Simulated Y-Site Administration Trissel Lawrence A, Trusley Craig, Kupiec Thomas C, Ben Michel	Jan/Feb 2009 Pg. 78-80
Palonosetron Hydrochloride Compatibility and Stability with Three Beta-Lactam Antibiotics During Simulated Y-Site Administration Ben Michel, Trusley Craig, Kupiec Thomas C, Trissel Lawrence A	Nov/Dec 2007 Pg. 520-524
Physical and Chemical Stability of Palonosetron Hydrochloride with Glycopyrrolate and Neostigmine During Simulated Y-Site Administration Ben Michel, Trusley Craig, Kupiec Thomas C, Trissel Lawrence A	Jul/Aug 2008 Pg. 368-371
Compatibility and Stability of Palonosetron Hydrochloride with Lactated Ringer's, Hetastarch in Lactated Electrolyte, and Mannitol Injections During Simulated Y-Site Administration Ben Michel, Kupiec Thomas C, Trusley Craig, Trissel Lawrence A	Sep/Oct 2008 Pg. 460-462
Physical and Chemical Stability of Palonosetron Hydrochloride with Topotecan Hydrochloride and Irinotecan Hydrochloride during Simulated Y-Site Administration Trissel Lawrence A, Xu Quanyun A	May/Jun 2005 Pg. 238-241
Physical and Chemical Stability of Palonosetron Hydrochloride with Lorazepam and Midazolam Hydrochloride during Simulated Y-Site Administration Trissel Lawrence A, Xu Quanyun A	May/Jun 2005 Pg. 235-237
Compatibility and Stability of Rolapitant Injectable Emulsion Admixed with Intravenous Palonosetron Hydrochloride Wu George, Yeung Stanley, Chen Frank	Jan/Feb 2017 Pg. 76-82
Compatibility and Stability of VARUBI (Rolapitant) Injectable Emulsion Admixed with Intravenous Palonosetron Hydrochloride Injection and Dexamethasone Sodium Phosphate Injection Wu George, Powers Dan, Yeung Stanley, Chen Frank	Jan/Feb 2018 Pg. 76-85
Compatibility Screening of Bivalirudin During Simulated Y-Site Administration with Other Drugs Trissel Lawrence A, Saenz Christopher	Jul/Aug 2002 Pg. 311-315
Physical and Chemical Stability of Palonosetron with Metoclopramide and Promethazine During Simulated Y-Site Administration Trusley Craig, Ben Michel, Kupiec Thomas C, Trissel Lawrence A	Jan/Feb 2007 Pg. 82-85
Physical and Chemical Stability of Palonosetron Hydrochloride with Fluorouracil and with Gemcitabine Hydrochloride during Simulated Y-site Administration Trissel Lawrence A, Zhang Yanping	Jul/Aug 2005 Pg. 320-322
Compatibility and Stability of VARUBI (Rolapitant) Injectable Emulsion Admixed with Intravenous Granisetron Hydrochloride Wu George, Powers Dan, Yeung Stanley, Chen Frank, Neelon Kelly	Jan/Feb 2018 Pg. 86-94
Compatibility of Amiodarone Hydrochloride with Vasopressin During Simulated Y-site Administration Ramaley Corrine C, Li Feng, Du Chengan	Sep/Oct 2013 Pg. 436-438
Physical and Chemical Stability of Palonosetron Hydrochloride with Dacarbazine and with Methylprednisolone Sodium Succinate During Simulated Y-Site Administration Trissel Lawrence A, Xu Quanyun A, Zhang Yanping	May/Jun 2006 Pg. 234-236
Compatibility and Stability of Ranitidine Hydrochloride with Six Cephalosporins During Simulated Y-Site Administration Inagaki Kazuhiro, Kambara Motoya, Mizuno Munemichi, Gill Mark A, Nishida Mikio	Jul/Aug 1998 Pg. 318-321
Rolapitant Injectable Emulsion with Palonosetron Hydrochloride Admixture Allen Loyd V Jr	Mar/Apr 2018 Pg. 151
Compatibility Screening of Hextend During Simulated Y-Site Administration with Other Drugs Trissel Lawrence A, Williams Kimberly Y, Baker Ma	Jan/Feb 2001 Pg. 69-73
Ondansetron Hydrochloride 2-mg/mL Injection Allen Loyd V Jr	Jul/Aug 2012 Pg. 339
Return to Top